Global Critical Care Devices Market is poised to accrue remarkable gains through 2032, credited to the growing demand for ventilators for disease management. Moreover, the increasing incidence of chronic respiratory disorders and the associated comorbidities has propelled the demand for ventilators. As per the NCD Alliance, an estimated 550 million people globally are diagnosed with chronic respiratory diseases.

Moreover, the growing emphasis of industry players on R&D activities for developing ventilators in therapeutic space is also working in favor of industry expansion. In fact, in January 2023, Getinge AB, a Swedish medical technology company, announced the launch of its new Servo-c mechanical ventilator, providing lung-protective therapeutic tools for the expansion of its ICU offerings.

Overall, the critical care devices market is segmented based on product, application, end-use, and region.

On the basis of product, the critical care devices industry from the ECG devices segment is expected to register significant gains through 2032, owing to ongoing product innovations in the field. For instance, in January 2022, Royal Philips, a global health technology provider, announced the launch of the first-ever at-home full-service 12-lead electrocardiogram (ECG) solution. It is a clinical-grade patient-focused ECG solution that pairs data readings comparable to clinical ECGs to bring innovation across the care continuum.

In terms of application, the critical care devices market share from the neurology segment is poised to grow at over 6% CAGR from 2023 to 2032. The growing occurrence of neurological diseases such as Alzheimer’s disease, multiple sclerosis (MS), traumatic brain injury, epilepsy, and others has proliferated the need for critical care devices. As per the WHO, epilepsy affects around 5 million people globally every year. Moreover, recent advancements in neurological devices will further create a strong impetus for segment expansion.

With respect to end-use, the critical care devices market size from the ambulatory surgical centers segment is anticipated to grow at a substantial CAGR from 2023 to 2032. The high availability of technologically advanced critical care devices and less cost of treatment has increased patient footfall in ambulatory surgical centers. Additionally, shorter hospital stays and low risk of hospital-acquired infections have made them the preferred healthcare provider for the treatment of severe diseases.

Regionally speaking, the Asia Pacific critical care devices market is slated to record a valuation of over USD 25 billion by 2032. The rising prevalence of severe illnesses such as cardiovascular disorders, cancer, and others has bolstered the demand for critical care devices in the region. As per the Journal of Thoracic Oncology, lung cancer makes up 8.1% of all cancer-related deaths in India. Regional growth can also be ascribed to the robust presence of prominent industry players such as Mindray, Asahi Kasei Corporation, and others who are consistently engaged in product innovations.